Morocco opts for weighting before adoption
The use of the antiviral Paxlovid (Pfizer) has been strongly recommended by the World Health Organization (WHO) for patients with less severe forms of Covid-19, but who are at a higher risk of hospitalization.
After its approval by the WHO, several countries will certainly resort to this anti-covid pill to deal with the disease. According to Pfizer, Paxlovid would reduce the risk of hospitalization and death by 85.2%. In France, the treatment has already been in pharmacies since February 4.
On the Moroccan side, the anti-covid scientific and technical committee had studied the effectiveness of this drug months ago but had not yet issued an official recommendation for its adoption in the Kingdom, for lack of complete technical and scientific data. about her.
In a statement to MoroccoLatestNewsan informed source within the anti-covid scientific and technical committee told us that “ all Covid-related drugs are discussed in detail within the committee. The focus is on studying their effectiveness in eliminating disease“.
In view of the stabilization of the epidemiological situation in our country, this member of the scientific committee believes that there is no ” need to adopt it now, except in the event of the emergence of a new global epidemiological wave“. At this moment, ” all effective drugs and treatments to fight the pandemic will be authorized“, he pointed out.
On the other hand, Pr Said Motaouakil, resuscitator anesthesiologist, estimated that ” Morocco is still adopting traditional methods of treating Covid, including vaccination and physical distancing. A strategy that has borne fruit over the past two years“, he clarified.
” The drug market is open in Morocco“, further underlined the resuscitation specialist, also a member of the anti-covid scientific and technical committee, noting that the country “ adopts every drug whose reliability is proven by scientific results, thus helping to contain diseases and pandemics“.
” Morocco adopted the drug hydroxychloroquine to fight the disease, then it authorized the use of the drug molnupiravir. And he could also adopt the drug Paxlovid if a fierce epidemic wave appears“, he says.
Thus, Morocco monitors all the mutations of the coronavirus around the world, and follows all the evolutions of the disease despite the stability of the epidemiological situation, including the drugs approved by the international health organizations, explained Pr Motaouakil.
It should be remembered that the drug Paxlovid, developed by the American laboratory ” Pfizer“, is used to treat patients with less severe forms of Covid-19 and at higher risk of hospitalization.
Only patients with a prescription will be able to access the treatment, provided they take it within five days of the onset of the onset of symptoms. It was approved by the Food and Drug Administration (FDA) of the United States, as well as by the British Medicines and Health Products Regulatory Agency.
.